Elena Vuelta

Alcala De Henares, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Functional assessment of inherited myeloid neoplasm-associated SAMD9L germline variants via Monoallelic CRISPR modelling.

Functional assessment of inherited myeloid neoplasm-associated SAMD9L germline variants via Monoallelic CRISPR modelling.

Journal: British journal of haematology

Published: January 12, 2026

C3G deregulation uncovers a dual role in B-cell lymphoma: tumor suppression and enhanced metastasis via Rap1 and Rac2 signaling.

C3G deregulation uncovers a dual role in B-cell lymphoma: tumor suppression and enhanced metastasis via Rap1 and Rac2 signaling.

Journal: Cell communication and signaling : CCS

Published: June 18, 2025

A Potential Effect of Circadian Rhythm in the Delivery/Therapeutic Performance of Paclitaxel-Dendrimer Nanosystems.

A Potential Effect of Circadian Rhythm in the Delivery/Therapeutic Performance of Paclitaxel-Dendrimer Nanosystems.

Journal: Journal of functional biomaterials

Published: June 13, 2023

Novel variants in GALE cause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesis.

Novel variants in GALE cause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesis.

Journal: Blood

Published: May 19, 2022

CRISPR/Cas9-Directed Gene Trap Constitutes a Selection System for Corrected BCR/ABL Leukemic Cells in CML.

CRISPR/Cas9-Directed Gene Trap Constitutes a Selection System for Corrected BCR/ABL Leukemic Cells in CML.

Journal: International journal of molecular sciences

Published: April 30, 2022

A novel nonsense variant in TPM4 caused dominant macrothrombocytopenia, mild bleeding tendency and disrupted cytoskeleton remodeling.

A novel nonsense variant in TPM4 caused dominant macrothrombocytopenia, mild bleeding tendency and disrupted cytoskeleton remodeling.

Journal: Journal of thrombosis and haemostasis : JTH

Published: November 21, 2021

CRISPR-Cas9 Technology as a Tool to Target Gene Drivers in Cancer: Proof of Concept and New Opportunities to Treat Chronic Myeloid Leukemia.

CRISPR-Cas9 Technology as a Tool to Target Gene Drivers in Cancer: Proof of Concept and New Opportunities to Treat Chronic Myeloid Leukemia.

Journal: The CRISPR journal

Published: August 18, 2021

Characterization of the Platelet Phenotype Caused by a Germline RUNX1 Variant in a CRISPR/Cas9-Generated Murine Model.

Characterization of the Platelet Phenotype Caused by a Germline RUNX1 Variant in a CRISPR/Cas9-Generated Murine Model.

Journal: Thrombosis and haemostasis

Published: February 24, 2021

Future Approaches for Treating Chronic Myeloid Leukemia: CRISPR Therapy.

Future Approaches for Treating Chronic Myeloid Leukemia: CRISPR Therapy.

Journal: Biology

Published: January 11, 2021

Stroma-Mediated Resistance to S63845 and Venetoclax through MCL-1 and BCL-2 Expression Changes Induced by miR-193b-3p and miR-21-5p Dysregulation in Multiple Myeloma.

Stroma-Mediated Resistance to S63845 and Venetoclax through MCL-1 and BCL-2 Expression Changes Induced by miR-193b-3p and miR-21-5p Dysregulation in Multiple Myeloma.

Journal: Cells

Published: December 23, 2020

Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology.

Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology.

Journal: Molecular biology reports

Published: September 13, 2019

Splice donor site sgRNAs enhance CRISPR/Cas9-mediated knockout efficiency.

Splice donor site sgRNAs enhance CRISPR/Cas9-mediated knockout efficiency.

Journal: PloS one

Published: February 07, 2019

Showing 1-12 of 12

Last Updated: 09/26/2026